These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15781396

  • 21. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
    Kam CM, Hernandez MA, Patil GS, Ueda T, Simmons WH, Braganza VJ, Powers JC.
    Arch Biochem Biophys; 1995 Feb 01; 316(2):808-14. PubMed ID: 7864637
    [Abstract] [Full Text] [Related]

  • 22. Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives.
    Costanzo MJ, Yabut SC, Zhang HC, White KB, de Garavilla L, Wang Y, Minor LK, Tounge BA, Barnakov AN, Lewandowski F, Milligan C, Spurlino JC, Abraham WM, Boswell-Smith V, Page CP, Maryanoff BE.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):2114-21. PubMed ID: 18272363
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Synthesis of potent and highly selective inhibitors of human tryptase.
    Slusarchyk WA, Bolton SA, Hartl KS, Huang MH, Jacobs G, Meng W, Ogletree ML, Pi Z, Schumacher WA, Seiler SM, Sutton JC, Treuner U, Zahler R, Zhao G, Bisacchi GS.
    Bioorg Med Chem Lett; 2002 Nov 04; 12(21):3235-8. PubMed ID: 12372541
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J, Fevig JM, Stouten PF, Alexander RS, Knabb RM, Wexler RR.
    Bioorg Med Chem Lett; 2000 Jun 05; 10(11):1253-6. PubMed ID: 10866393
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
    Miyazaki Y, Kato Y, Manabe T, Shimada H, Mizuno M, Egusa T, Ohkouchi M, Shiromizu I, Matsusue T, Yamamoto I.
    Bioorg Med Chem Lett; 2006 Jun 01; 16(11):2986-90. PubMed ID: 16540315
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D, McBride JD, Leatherbarrow RJ.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6045-52. PubMed ID: 15519150
    [Abstract] [Full Text] [Related]

  • 31. The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.
    Sommerhoff CP, Bode W, Pereira PJ, Stubbs MT, Stürzebecher J, Piechottka GP, Matschiner G, Bergner A.
    Proc Natl Acad Sci U S A; 1999 Sep 28; 96(20):10984-91. PubMed ID: 10500112
    [Abstract] [Full Text] [Related]

  • 32. Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors.
    Heinelt U, Herok S, Matter H, Wildgoose P.
    Bioorg Med Chem Lett; 2001 Jan 22; 11(2):227-30. PubMed ID: 11206465
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa.
    Matter H, Defossa E, Heinelt U, Blohm PM, Schneider D, Müller A, Herok S, Schreuder H, Liesum A, Brachvogel V, Lönze P, Walser A, Al-Obeidi F, Wildgoose P.
    J Med Chem; 2002 Jun 20; 45(13):2749-69. PubMed ID: 12061878
    [Abstract] [Full Text] [Related]

  • 35. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
    Tully DC, Vidal A, Chatterjee AK, Williams JA, Roberts MJ, Petrassi HM, Spraggon G, Bursulaya B, Pacoma R, Shipway A, Schumacher AM, Danahay H, Harris JL.
    Bioorg Med Chem Lett; 2008 Nov 15; 18(22):5895-9. PubMed ID: 18752942
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The arginine mimicking β-amino acid β³hPhe(3-H₂N-CH₂) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors.
    Janke D, Sommerhoff CP, Schaschke N.
    Bioorg Med Chem; 2011 Dec 01; 19(23):7236-43. PubMed ID: 22047802
    [Abstract] [Full Text] [Related]

  • 38. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.
    Choi-Sledeski YM, Kearney R, Poli G, Pauls H, Gardner C, Gong Y, Becker M, Davis R, Spada A, Liang G, Chu V, Brown K, Collussi D, Leadley R, Rebello S, Moxey P, Morgan S, Bentley R, Kasiewski C, Maignan S, Guilloteau JP, Mikol V.
    J Med Chem; 2003 Feb 27; 46(5):681-4. PubMed ID: 12593648
    [Abstract] [Full Text] [Related]

  • 39. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
    Stürzebecher J, Prasa D, Wikström P, Vieweg H.
    J Enzyme Inhib; 1995 Feb 27; 9(1):87-99. PubMed ID: 8568569
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.